IP Library Patent Application 16492793
Patent Application
App. No. 16/492,793

TYROSINE PROTOTROPHY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/492,793
Abstract

Provided herein is a tyrosine selection marker system, and uses thereof. In some embodiments, nucleic acid constructs, vectors, host cells and related compositions and methods for generating and selecting tyrosine prototroph cells are provided.

Claims (40)

1 . A recombinant nucleic acid construct comprising a nucleotide sequence of interest, and one or both of: i) a phenylalanine hydroxylase (PAH) gene, and ii) a pterin-4-alpha-carbinolamine dehydratase (PCBD1) gene.

2 . The recombinant nucleic acid construct of claim 1 , wherein the nucleic acid construct further comprises a recombination target sequence.

3 . The recombinant nucleic acid construct of claim 2 , wherein the recombination target sequence is a FLP Recognition Target (“FRT”), lox, or Bxb1 sequence.

4 . The recombinant nucleic acid construct of claim 1 , wherein the nucleotide sequence of interest encodes a polypeptide of interest, encodes an RNA molecule of interest, or contains a restriction enzyme site.

5 . The recombinant nucleic acid construct of claim 1 , wherein the nucleotide sequence of interest is a first nucleotide sequence of interest, and wherein the recombinant nucleic acid construct further comprises a second nucleotide sequence of interest.

6 . (canceled)

7 . (canceled)

8 . The recombinant nucleic acid construct of claim 5 , wherein the first nucleotide sequence of interest encodes a first polypeptide comprising an antibody variable light (VL) region and wherein the second nucleotide sequence of interest encodes a second polypeptide comprising an antibody variable heavy (VH) region.

9 . A vector comprising the recombinant nucleic acid construct of claim 1 .

10 . (canceled)

11 . (canceled)

12 . A host cell comprising the recombinant nucleic acid construct of claim 1 .

13 . A host cell comprising the recombinant nucleic acid construct of claim 1 , wherein the recombinant nucleic acid construct is stably integrated into a chromosome of the host cell.

14 . The host cell of claim 12 , wherein the host cell is a mammalian cell.

15 . The host cell of claim 14 , wherein the mammalian cell is a mouse cell, a human cell, or a Chinese hamster ovary (CHO) host cell.

16 . Use of a host cell of claim 12 for production of a polypeptide or RNA molecule encoded by the nucleotide sequence of interest.

17 . A recombinant polypeptide produced by the host cell of claim 12 .

18 . A composition comprising a host cell claim 12 , and a cell culture medium.

19 . A composition comprising a host cell, a recombinant nucleic acid construct of claim 1 , and a cell culture medium.

20 . (canceled)

21 . The composition of claim 18 , wherein the cell culture medium is tyrosine-deficient.

22 . The composition of claim 21 , wherein the cell culture medium comprises less than 1 mM tyrosine.

23 . (canceled)

24 . A method of producing a host cell comprising an exogenous nucleotide sequence of interest, the method comprising:

a) introducing into a host cell an exogenous nucleic acid construct comprising the nucleotide sequence of interest, wherein the exogenous nucleic acid construct further comprises: i) a PAH gene, and ii) a PCBD1 gene;

b) culturing the host cell comprising the exogenous nucleic acid construct in a tyrosine-deficient medium, wherein the host cell comprising the exogenous nucleic acid construct proliferates more rapidly in the tyrosine-deficient medium than a corresponding otherwise identical host cell that lacks the exogenous nucleic acid construct.

25 . The method of claim 24 , wherein the exogenous nucleic acid construct is stably integrated into a chromosome of the host cell.

26 . (canceled)

27 . A method of producing a host cell comprising a first exogenous nucleotide sequence of interest and a second exogenous nucleotide sequence of interest, the method comprising:

a) introducing into a host cell I) a first exogenous nucleic acid construct comprising i) the first exogenous nucleotide sequence of interest and ii) a PAH gene and II) a second exogenous nucleic acid construct comprising i) the second exogenous nucleotide sequence of interest and ii) a PCBD1 gene; and

b) culturing the host cell comprising the first exogenous nucleic acid construct and the second exogenous nucleic acid construct in a tyrosine-deficient medium, wherein the host cell comprising the first exogenous nucleic acid construct and the second exogenous nucleic acid construct proliferates more rapidly in the tyrosine-deficient medium than a corresponding otherwise identical host cell that lacks the first exogenous nucleic acid construct and second exogenous nucleic acid construct.

28 . The method of claim 27 , wherein the first exogenous nucleic acid construct and the second exogenous nucleic acid construct are both stably integrated into a first chromosome of the host cell, or wherein the first exogenous nucleic acid construct is stably integrated into a first chromosome of the host cell and the second exogenous nucleic acid construct is stably integrated into a second chromosome of the host cell.

29 . (canceled)

30 . (canceled)

31 . (canceled)

32 . The recombinant nucleic construct claim 1 , wherein at least one of:

i) the PAH gene encodes a polypeptide comprising the amino acid sequence shown in SEQ ID NO: 1, or a sequence with at least 80% homology thereof;

ii) the PAH gene comprises a DNA sequence shown in SEQ ID NO: 2, or a sequence with at least 80% homology thereof;

iii) the PCBD1 gene encodes a polypeptide comprising the amino acid sequence shown in SEQ ID NO: 3, or a sequence with at least 80% homology thereof; or

iv) the PCBD1 gene comprises a DNA sequence shown in SEQ ID NO: 4, or a sequence with at least 80% homology thereof.

Assignments (1)
ASSIGNEE ADDRESS CORRECTION Recorded Mar 20, 2023
From: PFIZER INC.
To: PFIZER INC.
Reel/Frame 063119/0087 →